Number of Shares
736,981.00
Current Holdings Value*
$436.19 Mil
% of Portfolio
3.83%
Total Estimate Gain
$359.79 Mil
% of Total Estimate Gain
163.13%

T. Rowe Price Health Sciences Fund, Inc.'s argenx SE Holding Summary

As of 2025-03-31, T. Rowe Price Health Sciences Fund, Inc. held 736,981.00 shares of argenx SE(ARGX), totaling $436.19 Mil. This investment constitutes 3.83% of their stock portfolio, and T. Rowe Price Health Sciences Fund, Inc. now holds 1.21% of the outstanding argenx SE(ARGX) stock.

The initial trade took place in 2019Q3. And since then T. Rowe Price Health Sciences Fund, Inc. has made 5 purchases of ARGX, at an average price of $197.48, for a total of 1.12 Mil shares. In addition, there have been 7 sales at an average price of $422.47 for 379,850.00 shares. Based on historical transaction data and ARGX's current price of $569.71, T. Rowe Price Health Sciences Fund, Inc.'s estimated gain on his ARGX holdings is $359.79 Mil, reflecting a 163.13% gain to date.

T. Rowe Price Health Sciences Fund, Inc. ARGX ($569.71) Holding Chart

T. Rowe Price Health Sciences Fund, Inc. ARGX ($569.71) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1